Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP802-247 in Venous Leg Ulcers
NCT01656889Phase 3Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Aug 2012
- Primary completion
- Dec 2014
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in venous leg ulcer (VLU) comparing HP802-247 with Vehicle (2 arms). Primary endpoint: Proportion of Subjects With Complete Wound Closure at 12 weeks. Started Aug 2012; status: completed.
02
Drugs
HP-802-247
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT01656889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656889.